Serial 87249341
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 23 Aug 2024)
What this means for you
Registered since 24 Oct 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Oct 2027: the §8 & §9 renewal).
Record
- Serial number
- 87249341
- Registration number
- 5315097
- Mark type
- Design / logo
- Filed
- 28 Nov 2016
- Published for opposition
- 08 Aug 2017
- Registered
- 24 Oct 2017
- Next maintenance filing
- §8 & §9 renewal, due by 24 Oct 2027 (grace period to 24 Apr 2028)
- Attorney of record
- Max Moskowitz
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the treatment of diabetes
Owner
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
- Boehringer Ingelheim International GmbH, Ingelheim, DE
Prosecution history
- 23 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 23 Aug 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 12 Feb 2024 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 12 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 24 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 08 Aug 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Aug 2017 — PUBLISHED FOR OPPOSITION
- 19 Jul 2017 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jun 2017 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Jun 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 26 Jun 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 26 Jun 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED